GSK receives European authorisation for once-weekly type 2 diabetes treatment, Eperzan®
26 March 2014 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the European Commission has granted marketing authorisation for its once-weekly diabetes treatment, Eperzan® (albiglutide)...